Cancer News and Research

Latest Cancer News and Research

New research could potentially yield novel platform for cancer vaccines

New research led by Wyss Core Faculty member David Mooney, Ph.D., in collaboration with researchers at the Dana-Farber Cancer Institute could potentially yield a new platform for cancer vaccines. Leveraging a biologically inspired sponge-like gel called "cryogel" as an injectable biomaterial, the vaccine delivers patient-specific tumor cells together with immune-stimulating biomolecules to enhance the body's attack againstcancer.

26 Aug 2015

TUHS, GE Healthcare collaborate to provide high-quality radiologic imaging services

Academic medical centers across the U.S. are experiencing increasing pressure to enhance value - deliver higher quality at lower cost - as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency and quality incentives.

26 Aug 2015

Persistent leukemia-associated genetic mutations linked to increased risk of relapse, reduced overall survival

In preliminary research, the detection of persistent leukemia-associated genetic mutations in at least 5 percent of bone marrow cells in day 30 remission samples among adult patients with acute myeloid leukemia was associated with an increased risk of relapse and reduced overall survival, according to a study in the August 25 issue of JAMA.

26 Aug 2015

Moffitt researchers discover high BRCA mutation frequency in young black women with breast cancer

Women who have inherited mutations in the BRCA1 or BRCA2 genes are more likely to develop breast cancer or ovarian cancer, especially at a younger age. Approximately 5 percent of women with breast cancer in the United States have mutations in BRCA1 or BRCA2 based on estimates in non-Hispanic white women.

26 Aug 2015

Study reveals how inflammation triggers colon cancer cells to metastasize

A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois, M.D., Ph.D., has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.

26 Aug 2015

Lingering cancer-related mutations linked to increased risk of relapse, poor survival in leukemia patients

For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations - detected after initial treatment with chemotherapy - are associated with an increased risk of relapse and poor survival.

26 Aug 2015

New assessment tool under development can help detect physical traits of Klinefelter syndrome

Klinefelter syndrome is the most common disorder of the male sex chromosomes, yet is rarely diagnosed in children. A new assessment tool is being developed by researchers at Columbia University Medical Center (CUMC) to help pediatricians detect the physical traits of the syndrome. The tool could pave the way for early interventions that prevent and treat a range of physical, psychological, social, and cognitive impairments.

26 Aug 2015

MorphoSys, Immatics partner to develop novel antibody-based therapies against multiple proprietary cancer antigens

MorphoSys AG and Immatics Biotechnologies GmbH announced today a strategic alliance to generate novel antibody-based therapeutics against multiple proprietary cancer antigens recognized by T cells.

26 Aug 2015

NYU Langone Medical Center gets multimillion dollar gift to support expansion of multispecialty ambulatory sites

NYU Langone Medical Center announced a generous multimillion dollar gift from Joan H. Tisch to establish the new Joan H. and Preston Robert Tisch Center at Essex Crossing, and to expand the existing Preston Robert Tisch Center for Men's Health.

26 Aug 2015

AirXpanders' pivotal XPAND trial meets primary endpoint in patients who have undergone mastectomy

AirXpanders Inc., a medical device company focused on the design, manufacture, sale and distribution of the AeroForm Tissue Expander, is pleased to report that its pivotal XPAND trial has met its primary endpoint in patients who have undergone a mastectomy.

26 Aug 2015

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.

26 Aug 2015

Chrono obtains second Fast Track SBIR grant award from NCI to support development of smoking cessation therapy

Chrono Therapeutics, a pioneer in digital drug therapy, today announced it has received a second Phase 1 and Phase 2 Fast Track Small Business Innovation Research (SBIR) grant award from the National Cancer Institute.

26 Aug 2015

Tocagen's Toca 511 & Toca FC receives FDA orphan drug designation for treatment of glioblastoma

Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.

26 Aug 2015

Sequenom, UC San Diego Moores Cancer Center collaborate to explore utility of liquid biopsy assay

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.

26 Aug 2015

Study reveals potential health risks associated with burning of incense in indoor environments

The burning of incense might need to come with a health warning. This follows the first study evaluating the health risks associated with its indoor use. The effects of incense and cigarette smoke were also compared, and made for some surprising results. The research was led by Rong Zhou of the South China University of Technology and the China Tobacco Guangdong Industrial Company in China, and is published in Springer's journal Environmental Chemistry Letters.

25 Aug 2015

Leukemia & Lymphoma Society to kick off 2015 Light The Night Walk campaign throughout Northern California

The Leukemia & Lymphoma Society will be kicking off its 2015 Light The Night Walk campaign throughout Northern California with the Napa Valley Walk on September 26, 2015 at 5 p.m. PT at Veterans Memorial Park.

25 Aug 2015

Special issue in Future Science OA explores nitric oxide in human medicine

Future Science Group today announced the publication of a special issue in Future Science OA, covering the rapidly evolving field of nitric oxide (NO) in human medicine.

25 Aug 2015

MU researchers find that resveratrol affects dogs' immune systems in different ways

Resveratrol, a compound found commonly in grape skins and red wine, has been shown to have several potentially beneficial effects on health, including cardiovascular health, stroke prevention and cancer treatments. However, scientists do not yet fully understand how the chemical works and whether or not it can be used for treatment of diseases in humans and animals.

25 Aug 2015

Irreversible electroporation may prolong survival rates of patients with locally advanced pancreatic cancer

Use of irreversible electroporation (IRE) doubles the survival time for patients with locally advanced pancreatic cancer say researchers at the University of Louisville in a paper in the September edition of the Annals of Surgery.

25 Aug 2015

New TSRI study may have important implications for better drug design

Scientists from The Scripps Research Institute Florida campus have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output. These new findings could aid future drug design by giving scientists an edge in fine tuning the signal between these partnered proteins—and the drug's course of action.

25 Aug 2015

Cancer News and Research

Latest Cancer News and Research

New research could potentially yield novel platform for cancer vaccines

TUHS, GE Healthcare collaborate to provide high-quality radiologic imaging services

Persistent leukemia-associated genetic mutations linked to increased risk of relapse, reduced overall survival

Moffitt researchers discover high BRCA mutation frequency in young black women with breast cancer

Study reveals how inflammation triggers colon cancer cells to metastasize

Lingering cancer-related mutations linked to increased risk of relapse, poor survival in leukemia patients

New assessment tool under development can help detect physical traits of Klinefelter syndrome

MorphoSys, Immatics partner to develop novel antibody-based therapies against multiple proprietary cancer antigens

NYU Langone Medical Center gets multimillion dollar gift to support expansion of multispecialty ambulatory sites

AirXpanders' pivotal XPAND trial meets primary endpoint in patients who have undergone mastectomy

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Chrono obtains second Fast Track SBIR grant award from NCI to support development of smoking cessation therapy

Tocagen's Toca 511 & Toca FC receives FDA orphan drug designation for treatment of glioblastoma

Sequenom, UC San Diego Moores Cancer Center collaborate to explore utility of liquid biopsy assay

Study reveals potential health risks associated with burning of incense in indoor environments

Leukemia & Lymphoma Society to kick off 2015 Light The Night Walk campaign throughout Northern California

Special issue in Future Science OA explores nitric oxide in human medicine

MU researchers find that resveratrol affects dogs' immune systems in different ways

Irreversible electroporation may prolong survival rates of patients with locally advanced pancreatic cancer

New TSRI study may have important implications for better drug design

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in